Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
Fibroblast Activation Protein Inhibitor (FAPI)-Based TheranosticsWilliam Serumula, Venesen Pillay, Bawinile Hadebe, et al.
Diagnostics (Basel, Switzerland)|February 25, 2023
The Role of PET/CT in Breast CancerBawinile Hadebe, Lerwine Harry, Tasmeera Ebrahim, et al.
Clinical Nuclear Medicine|May 24, 2021
Comparing 99mTc-PSMA to 99mTc-MDP in Prostate Cancer Staging of the Skeletal SystemJoseph Kabunda, Lerato Gabela, Chester Kalinda, et al.
Hellenic Journal of Nuclear Medicine|December 7, 2024
Efficacy of a fixed low dose of radioactive iodine in the treatment of Graves' disease in Sub-Saharan AfricaSphelele Masikane, Thokozani Mkhiz, Lerwine Harry, et al.
Diagnostics (Basel, Switzerland)|March 27, 2024
A Comparison of <sup>68</sup>Ga-PSMA PET/CT-Based Split Renal Function with <sup>99m</sup>Tc-MAG3 Renography in Patients with Metastatic Castration-Resistant Prostate Carcinoma Treated with <sup>177</sup>Lu-PSMALerato Gabela, Thokozani Mkhize, Bawinile Hadebe, et al.
Cancers|March 13, 2025
Comparing <sup>68</sup>Ga-Pentixafor,<sup>18</sup>F-FDG PET/CT and Chemokine Receptor 4 Immunohistochemistry Staining in Breast Cancer: A Prospective Cross Sectional StudyBawinile Hadebe, Lerwine Harry, Lerato Gabela, et al.
Diagnostics (Basel, Switzerland)|July 13, 2024
Chemokine Receptor-4 Targeted PET/CT Imaging with <sup>68</sup>Ga-Pentixafor in Head and Neck Cancer-A Comparison with <sup>18</sup>F-FDG and CXCR4 ImmunohistochemistryBawinile Hadebe, Lerwine Harry, Lerato Gabela, et al.
Pageof 1